Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues

Molecular Reproduction and Development

Volumn 80, Issue 11, 2013, Pages 948-958

  Nteeba, J ^a   Ortinau, L C ^b   Perfield, J W ^b,c,d   Keating, A F ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; I KAPPA B KINASE BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA 125B; MICRORNA 143; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P55; PROTEIN P75; RANTES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; FAT INTAKE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL SIZE; FEMALE; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INFLAMMATION; LIPID DIET; MOUSE; NONHUMAN; OBESITY; OVARY FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ADMINISTRATION AND DOSAGE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FAT INTAKE; METABOLISM; OVARY; PHARMACOLOGY;

MUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CELL SIZE; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; FEMALE; GENE EXPRESSION; INFLAMMATION; MICE; MICE, INBRED C57BL; OBESITY; OVARY;

EID: 84887992771     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.22231     Document Type: Article

References (93)

1. Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, Canevari S, Tomassetti A. 2012. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFκB pathway in advanced-stage epithelial ovarian cancer. Oncogene 31:4139-4149.
2. Adashi EY. 1990. The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 11:454-464.
3. Agarwal A, Gupta S, Sharma R. 2005a. Oxidative stress and its implications in female infertility - a clinician's perspective. Reprod Biomed Online 11:641-650.
4. Agarwal A, Gupta S, Sharma RK. 2005b. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3:28.
5. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. 2006. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl 27:335-347.
6. Amsterdam A, Keren-Tal I, Aharoni D, Dantes A, Land-Bracha A, Rimon E, Sasson R, Hirsh L. 2003a. Steroidogenesis and apoptosis in the mammalian ovary. Steroids 68:861-867.
7. Amsterdam A, Sasson R, Keren-Tal I, Aharoni D, Dantes A, Rimon E, Land A, Cohen T, Dor Y, Hirsh L. 2003b. Alternative pathways of ovarian apoptosis: death for life. Biochem Pharmacol 66:1355-1362.
8. Andreani CL, Payne DW, Packman JN, Resnick CE, Hurwitz A, Adashi EY. 1991. Cytokine-mediated regulation of ovarian function. Tumor necrosis factor alpha inhibits gonadotropin-supported ovarian androgen biosynthesis. Journal of Biological Chemistry 266:6761-6766.
9. Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, Chakravarty P, Gorringe KL, Campbell IG, Okamoto A, Birrer MJ, Huntsman DG, de Fazio A, Kalloger SE, Balkwill F, Gilks CB, Bowtell DD, Group AOCS. 2011. IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res 17:2538-2548.
10. Benyo DF, Pate JL. 1992. Tumor necrosis factor-alpha alters bovine luteal cell synthetic capacity and viability. Endocrinology 130:854-860.
11. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L, Lawn JE. 2012. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 379:2162-2172.
12. Brännström M, Norman RJ, Seamark RF, Robertson SA. 1994. Rat ovary produces cytokines during ovulation. Biol Reprod 50:88-94.
13. Buyalos RP, Watson JM, Martinez-Maza O. 1992. Detection of interleukin-6 in human follicular fluid. Fertil Steril 57:1230-1234.
14. Carlberg M, Nejaty J, Fröysa B, Guan Y, Söder O, Bergqvist A. 2000. Elevated expression of tumour necrosis factor alpha in cultured granulosa cells from women with endometriosis. Hum Reprod 15:1250-1255.
15. Carmichael SL, Rasmussen SA, Shaw GM. 2010. Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol 88:804-810.
16. Chou CH, Wei LH, Kuo ML, Huang YJ, Lai KP, Chen CA, Hsieh CY. 2005. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Carcinogenesis 26:45-52.
17. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. 2005. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347-2355.
18. Cohen PE, Nishimura K, Zhu L, Pollard JW. 1999. Macrophages: important accessory cells for reproductive function. J Leukoc Biol 66:765-772.
19. Costanzo ES, Lutgendorf SK, Sood AK, Anderson B, Sorosky J, Lubaroff DM. 2005. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104:305-313.
20. Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirström K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR. 2011. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17:6083-6096.
21. Crespo D, Bonnet E, Roher N, MacKenzie SA, Krasnov A, Goetz FW, Bobe J, Planas JV. 2010. Cellular and molecular evidence for a role of tumor necrosis factor alpha in the ovulatory mechanism of trout. Reprod Biol Endocrinol 8:34.
22. Cummings DE, Schwartz MW. 2003. Genetics and pathophysiology of human obesity. Annu Rev Med 54:453-471.
23. Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. 2002. Silibinin inhibits constitutive and TNFα-induced activation of NFκB and sensitizes human prostate carcinoma DU145 cells to TNFα-induced apoptosis. Oncogene 21:1759-1767.
24. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. 2006. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12:5055-5063.
25. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
26. Fernandez-Valverde SL, Taft RJ, Mattick JS. 2011. MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 60:1825-1831.
27. Ferrante AW. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 262:408-414.
28. Gazvani MR, Bates M, Vince G, Christmas S, Lewis-Jones DI, Kingsland C. 2000. Follicular fluid concentrations of interleukin-12 and interleukin-8 in IVF cycles. Fertil Steril 74:953-958.
29. Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377.
30. Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U. 2009. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab 297:E999-E1003.
31. Hefler LA, Gregg AR. 2002. Inducible and endothelial nitric oxide synthase: genetic background affects ovulation in mice. Fertil Steril 77:147-151.
32. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 2000. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America 97:12729-12734.
33. Hirshfield AN. 1991. Development of follicles in the mammalian ovary. Int Rev Cytol 124:43-101.
34. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM. 1994. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270.
35. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860-867.
36. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415.
37. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91.
38. Huang HC, Yu HR, Huang LT, Chen RF, Lin IC, Ou CY, Hsu TY, Yang KD. 2012. miRNA-125b regulates TNF-α production in CD14+ neonatal monocytes via post-transcriptional regulation. J Leukoc Biol 92:171-182.
39. Jabbour HN, Sales KJ, Catalano RD, Norman JE. 2009. Inflammatory pathways in female reproductive health and disease. Reproduction 138:903-919.
40. Kern PA. 1997. Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity. J Nutr 127:1917S-1922S.
41. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. 1995. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119.
42. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F. 2007. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67:585-592.
43. Lane D, Matte I, Rancourt C, Piché A. 2011. Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer 11:210.
44. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW. 2000. Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 17:222-228.
45. Loret de Mola JR, Baumgardner GP, Goldfarb JM, Friedlander MA. 1996a. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. Hum Reprod 11:1377-1380.
46. Loret de Mola JR, Flores JP, Baumgardner GP, Goldfarb JM, Gindlesperger V, Friedlander MA. 1996b. Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome: ovarian immunohistochemical localization of interleukin-6 signal. Obstet Gynecol 87:581-587.
47. Lumeng CN, Bodzin JL, Saltiel AR. 2007a. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184.
48. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. 2007b. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56:16-23.
49. Ma CH, Yan LY, Qiao J, Sha W, Li L, Chen Y, Sun QY. 2010. Effects of tumor necrosis factor-alpha on porcine oocyte meiosis progression, spindle organization, and chromosome alignment. Fertil Steril 93:920-926.
50. Malnick SD, Knobler H. 2006. The medical complications of obesity. QJM 99:565-579.
51. Mercurio F, Murray BW, Shevenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M, Manning AM. 1999. Ikappa B kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol 19:1526-1538.
52. Mikuni M. 1995. [Effect of interleukin-2 and interleukin-6 on ovary in the ovulatory period-establishment of the new ovarian perfusion system and influence of interleukins on ovulation rate and steroid secretion]. Hokkaido Igaku Zasshi 70:561-572.
53. Moller DE. 2000. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212-217.
54. Nestler JE. 2000. Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 24:S71-73.
55. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG, Olefsky JM. 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. JBiolChem 282:35279-35292.
56. Nickelson KJ, Stromsdorfer KL, Pickering RT, Liu TW, Ortinau LC, Keating AF, Perfield JW. 2012. A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice. Exp Diabetes Res 2012:859395.
57. Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 282:29919-29926.
58. Norman RJ, Brannstrom M. 1994. White cells and the ovary-incidental invaders or essential effectors? J Endocrinol 140:333-336.
59. Ogbuji QC. 2010. Obesity and reproductive performance in women. Afr J Reprod Health 14:143-151.
60. Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M, Gómez-Ambrosi J, Anglada R, Fernández-Formoso JA, Ricart W, Frühbeck G, Fernández-Real JM. 2013. Targeting the Circulating MicroRNA Signature of Obesity. Clin Chem 59:781-792.
61. Osborn BH, Haney AF, Misukonis MA, Weinberg JB. 2002. Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fertil Steril 77:46-51.
62. Pasquali R, Gambineri A. 2006. Metabolic effects of obesity on reproduction. Reprod Biomed Online 12:542-551.
63. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. 2003. Obesity and reproductive disorders in women. Hum Reprod Update 9:359-372.
64. Perreault M, Marette A. 2001. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138-1143.
65. Pettigrew R, Hamilton-Fairley D. 1997. Obesity and female reproductive function. Br Med Bull 53:341-358.
66. Pierce JD, Cackler AB, Arnett MG. 2004. Why should you care about free radicals? RN 67:38-42 quiz 43.
67. Qiao J, Feng HL. 2011. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 17:17-33.
68. Rachoń D, Teede H. 2010. Ovarian function and obesity-interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 316:172-179.
69. Raj M, Kumar RK. 2010. Obesity in children & adolescents. Indian J Med Res 132:598-607.
70. Roby KF, Terranova PF. 1990. Effects of tumor necrosis factor-alpha in vitro on steroidogenesis of healthy and atretic follicles of the rat: theca as a target. Endocrinology 126:2711-2718.
71. Roby KF, Weed J, Lyles R, Terranova PF. 1990. Immunological evidence for a human ovarian tumor necrosis factor-alpha. J Clin Endocrinol Metab 71:1096-1102.
72. Rosselli M, Keller PJ, Dubey RK. 1998. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update 4:3-24.
73. Rubens CE, Gravett MG, Victora CG, Nunes TM, Group GR. 2010. Global report on preterm birth and stillbirth (7 of 7): mobilizing resources to accelerate innovative solutions (Global Action Agenda). BMC Pregnancy Childbirth 10:S7.
74. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. 1996. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116.
75. Sakumoto R, Okuda K. 2004. Possible actions of tumor necrosis factor-alpha in ovarian function. J Reprod Dev 50:39-46.
76. Salmassi A, Lü S, Hedderich J, Oettinghaus C, Jonat W, Mettler L. 2001. Interaction of interleukin-6 on human granulosa cell steroid secretion. J Endocrinol 170:471-478.
77. Schreyer SA, Chua SC, LeBoeuf RC. 1998. Obesity and diabetes in TNF-alpha receptor- deficient mice. J Clin Invest 102:402-411.
78. Sonkoly E, Pivarcsi A. 2009. Advances in microRNAs: implications for immunity and inflammatory diseases. Journal of Cellular and Molecular Medicine 13:24-38.
79. Spangelo BL, Judd AM, Call GB, Zumwalt J, Gorospe WC. 1995. Role of the cytokines in the hypothalamic-pituitary-adrenal and gonadal axes. Neuroimmunomodulation 2:299-312.
80. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, Defuria J, Jick Z, Greenberg AS, Obin MS. 2007. Adipocyte Death, Adipose Tissue Remodeling and Obesity Complications. Diabetes 56:2910-2918.
81. Stubbins RE, Najjar K, Holcomb VB, Hong J, Nunez NP. 2012. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obesity & Metabolism 14:58-66.
82. Szczepańska M, Koźlik J, Skrzypczak J, Mikolajczyk M. 2003. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 79:1288-1293.
83. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 88:9292-9296.
84. Teede HJ, Lombard C, Deeks AA. 2010. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 13:203-209.
85. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649-653.
86. Van der Hoek KH, Woodhouse CM, Brännström M, Norman RJ. 1998. Effects of interleukin (IL)-6 on luteinizing hormone- and IL-1beta-induced ovulation and steroidogenesis in the rat ovary. Biol Reprod 58:1266-1271.
87. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. 2003a. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808.
88. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. 2003b. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808.
89. Wellen KE, Hotamisligil GS. 2003. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788.
90. Williams MD, Mitchell GM. 2012. MicroRNAs in insulin resistance and obesity. Exp Diabetes Res 2012:484696.
91. Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL. 2004. Macrophage contributions to ovarian function. Hum Reprod Update 10:119-133.
92. Xie H, Lim B, Lodish HF. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58:1050-1057.
93. Zhang J, Ji X, Zhou D, Li Y, Lin J, Liu J, Luo H, Cui S. 2013. miR-143 is critical for the formation of primordial follicles in mice. Frontiers in bioscience: a journal and virtual library 18:588-597.